Boehringer streamlines NGS through partnershipNovember 14, 2019An enhanced partnership between Boehringer Ingelheim and biopharmaceutical research and development (R&D) provider, Genedata, is set to automate the pharmaceutical company’s complex cell line development processes.
SPONSORED CONTENTTake Control With ProHeart 12 (moxidectin)One dose offers year-long protection with a single injection, putting compliance in your hands. + Learn more